tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market

Spago Nanomedical AB (7UX) Financial Statements

Compare
0 Followers

Spago Nanomedical AB Financial Overview

Spago Nanomedical AB's market cap is currently €7.28M. The company's EPS TTM is €; its P/E ratio is -2.00; Spago Nanomedical AB is scheduled to report earnings on February 5, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 1.91Mkr 437.00Kkr 1.20Mkr 1.05Mkr 660.00K
Gross Profitkr -12.36Mkr -19.38Mkr -23.28Mkr -15.60Mkr -16.78M
Operating Incomekr -33.71Mkr -30.86Mkr -47.23Mkr -39.47Mkr -39.19M
EBITDAkr -33.40Mkr -26.39Mkr -42.22Mkr -38.73Mkr -38.69M
Net Incomekr -32.51Mkr -26.55Mkr -42.22Mkr -39.31Mkr -39.08M
Balance Sheet
Cash & Short-Term Investmentskr 32.47Mkr 29.67Mkr 45.22Mkr 62.10Mkr 52.46M
Total Assetskr 39.58Mkr 36.68Mkr 52.98Mkr 205.95Mkr 191.62M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -32.47Mkr -29.67Mkr -45.22Mkr -62.10Mkr -52.46M
Total Liabilitieskr 6.35Mkr 5.94Mkr 11.67Mkr 8.80Mkr 6.81M
Stockholders' Equitykr 33.23Mkr 30.75Mkr 41.32Mkr 197.16Mkr 184.81M
Cash Flow
Free Cash Flowkr -34.90Mkr 0.00kr -45.06Mkr -42.02Mkr -40.20M
Operating Cash Flowkr -34.67Mkr -28.30Mkr -44.91Mkr -38.19Mkr -35.57M
Investing Cash Flowkr -230.00Kkr 633.00Kkr -506.00Kkr -3.83Mkr -4.63M
Financing Cash Flowkr 22.15Mkr 24.87Mkr 28.53Mkr 51.66Mkr 64.21M
Currency in SEK

Spago Nanomedical AB Earnings and Revenue History

Spago Nanomedical AB Debt to Assets

Spago Nanomedical AB Cash Flow

Spago Nanomedical AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.